Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.45 Billion GBP | -9.43% |
| 2022 | 10.44 Billion GBP | 953.48% |
| 2021 | 991 Million GBP | 103.49% |
| 2020 | 487 Million GBP | -24.14% |
| 2019 | 642 Million GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.85 Billion GBP | 0.0% |
| 2024 Q1 | - GBP | -100.0% |
| 2023 Q3 | - GBP | -100.0% |
| 2023 FY | 9.45 Billion GBP | -9.43% |
| 2023 Q4 | 9.45 Billion GBP | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | 9.86 Billion GBP | 0.0% |
| 2022 Q3 | 12.03 Billion USD | 17.4% |
| 2022 Q4 | 10.44 Billion GBP | -13.27% |
| 2022 Q2 | 10.25 Billion GBP | 8.58% |
| 2022 FY | 10.44 Billion GBP | 953.48% |
| 2022 Q1 | 9.44 Billion GBP | 852.88% |
| 2021 FY | 991 Million GBP | 103.49% |
| 2021 Q4 | 991 Million GBP | 0.0% |
| 2021 Q1 | - GBP | 0.0% |
| 2020 FY | 487 Million GBP | -24.14% |
| 2019 FY | 642 Million GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.75 Billion USD | -243.789% |
| Bausch Health Companies Inc. | 22.38 Billion USD | 57.763% |
| Catalent, Inc. | 4.98 Billion USD | -89.575% |
| Emergent BioSolutions Inc. | 877.5 Million USD | -977.607% |
| Elanco Animal Health Incorporated | 5.77 Billion USD | -63.769% |
| Perrigo Company plc | 4.07 Billion USD | -132.14% |
| Teva Pharmaceutical Industries Limited | 20.15 Billion USD | 53.079% |
| Zoetis Inc. | 6.8 Billion USD | -38.998% |